Dr. Lacey Anderson explains how different medications help control high blood pressure and shares details on a new Tecton ...
Although pharmacologic agents remain first-line therapy for migraine, neuromodulation has emerged as a noninvasive, drug-free alternative. The US Food and Drug Administration-cleared REN device ...
Ac-SSO110 has received U.S. FDA Orphan Drug DesignationInitial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026Potential to ...
The firm has begun dosing extensive-stage small cell and Merkel cell cancer patients with 225Ac-SSO110 in a Phase I/II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback